Statute Details
- Title: Medicines (Export Licence for Psychotropic Substances) Regulations
- Act Code: MA1975-RG9
- Legislative Type: Subsidiary legislation (sl)
- Authorising Act: Medicines Act (Cap. 176), sections 22 and 74
- Citation: Rg 9; G.N. No. S 216/1994; Revised Edition 2000 (31 Jan 2000)
- Status: Current version as at 27 Mar 2026
- Key Provisions: Regulation 2 (definitions); Regulation 3 (licensing requirement); Regulation 4 (application process and discretion); Regulation 5 (fee and no refund); Regulation 6 (penalty)
- Schedule: Defines “psychotropic substance” by reference to substances specified in the Schedule
- Commencement Date: Not stated in the provided extract
What Is This Legislation About?
The Medicines (Export Licence for Psychotropic Substances) Regulations (“Export Licence Regulations”) create a controlled export regime for psychotropic substances and medicinal products that contain such substances. In practical terms, the Regulations prohibit the export of these controlled materials from Singapore unless the exporter holds a valid export licence and complies with the licence’s terms and conditions.
The Regulations sit within Singapore’s broader medicines and controlled substances framework. They are designed to prevent diversion, unlawful trafficking, and unsafe or unauthorised cross-border movement of medicines and chemicals that can affect the central nervous system. By requiring licensing at the point of export, the licensing authority can assess legitimacy, monitor quantities and destinations, and impose conditions that reduce regulatory and public safety risks.
Although the Regulations are relatively short, they are operationally significant: they establish (i) what counts as an “export” and a “psychotropic substance”, (ii) when an export licence is mandatory, (iii) how applications are made and how licences are granted, (iv) the fee payable, and (v) the criminal consequences for non-compliance.
What Are the Key Provisions?
1. Definitions (Regulation 2)
The Regulations define “export” and “psychotropic substance”, and also define “export licence”. “Export” means taking (or causing to be taken) out of Singapore by land, air or water, otherwise than in transit. This definition is important for compliance because it captures not only the physical act of exporting but also arrangements where a person “causes” export to occur. For practitioners, this can broaden potential liability to parties involved in logistics, contracting, or shipment arrangements.
“Psychotropic substance” is defined by reference to substances specified in the Schedule. This is a classic regulatory technique: rather than listing substances in the body of the Regulations, the Schedule identifies the controlled items. Accordingly, legal advice often turns on whether the relevant substance (or medicinal product ingredient) is included in the Schedule at the relevant time.
2. Core prohibition and licensing requirement (Regulation 3)
Regulation 3 is the central operative rule. It provides that a person must not export any consignment of either: (a) a psychotropic substance; or (b) a medicinal product containing any psychotropic substance—unless two conditions are met.
The first condition is that the person possesses a valid export licence for that consignment. The second condition is that the export is in accordance with the terms and conditions specified in the export licence. This means compliance is not merely “having a licence”; it is also “exporting within the licence’s scope”. If the licence specifies quantities, destinations, recipients, dates, packaging, documentation requirements, or other conditions, deviation can constitute a contravention.
From a legal risk perspective, Regulation 3 creates a strict compliance framework. Even if the exporter believes the shipment is legitimate, exporting outside the licence terms may trigger criminal liability under Regulation 6.
3. Application process and discretion (Regulation 4)
Regulation 4 sets out the administrative pathway. An application for an export licence must be made to the licensing authority in such form and manner as the authority may require. This gives the authority procedural flexibility (for example, requiring specific forms, supporting documents, declarations, or evidence of end-use).
Upon receipt of an application, the licensing authority may, in his discretion, grant an export licence subject to such terms and conditions as the authority thinks fit. Two points matter for practitioners:
- Discretion: The authority is not obliged to grant a licence even if an application is complete. This affects how counsel should frame submissions and manage expectations.
- Conditions: The authority can impose terms and conditions it considers appropriate. These conditions become legally binding for the exporter once the licence is granted.
In practice, this discretion can be relevant in disputes about refusal, delays, or the scope of conditions. While the extract does not include review mechanisms, the discretionary nature of the decision is a key feature to flag in legal analysis.
4. Fee and no refund (Regulation 5)
Regulation 5 provides that the fee for an export licence is $111. It also states that there shall be no refund of any fee paid under these Regulations. For commercial clients, this is a straightforward cost rule, but it can be important in procurement and compliance budgeting—especially where applications may be rejected or where shipments are cancelled after payment.
5. Penalty for contravention (Regulation 6)
Regulation 6 creates criminal liability for contravening or failing to comply with Regulation 3. The offence is punishable on conviction by a fine not exceeding $2,000, or imprisonment for a term not exceeding 6 months, or both.
For practitioners, the key compliance takeaway is that the offence is triggered by contravention of Regulation 3—meaning both (i) exporting without a valid export licence for the consignment, and (ii) exporting in breach of the licence’s terms and conditions. The penalty provision underscores that non-compliance is not merely administrative; it is a prosecutable offence.
How Is This Legislation Structured?
The Regulations are structured as a short instrument with a conventional layout:
- Regulation 1 (Citation): Provides the short title.
- Regulation 2 (Definitions): Defines key terms including “export”, “export licence”, and “psychotropic substance” (by reference to the Schedule).
- Regulation 3 (Licence to export psychotropic substance): Establishes the prohibition and the licensing conditions.
- Regulation 4 (Application for export licence): Sets out how to apply and the licensing authority’s discretion and ability to impose conditions.
- Regulation 5 (Fee): Fixes the licence fee and provides that it is non-refundable.
- Regulation 6 (Penalty): Creates the offence and sets the maximum penalties.
- The Schedule: Specifies the substances that qualify as “psychotropic substances”.
Notably, the extract does not show additional procedural provisions (such as appeals, suspension, or revocation). However, the licensing authority’s discretion in Regulation 4 and the binding nature of licence conditions in Regulation 3 are central to how the regime operates.
Who Does This Legislation Apply To?
The Regulations apply to “a person” who exports (or causes export) of a consignment containing psychotropic substances or medicinal products containing such substances. This broad phrasing can capture multiple categories of actors, including manufacturers, wholesalers, distributors, exporters, freight forwarders, and potentially other parties who arrange or facilitate export.
Because “export” includes taking or causing to be taken out of Singapore, liability risk may extend beyond the party that physically ships the goods. Practitioners advising corporate clients should therefore consider contractual and operational roles: who prepares shipping documentation, who instructs carriers, who holds the licence, and who controls compliance with licence conditions.
Why Is This Legislation Important?
Although the Regulations are concise, they are highly consequential for anyone involved in cross-border trade in controlled medicines. The licensing requirement is a gatekeeping mechanism: without a valid export licence for the specific consignment, export is prohibited. This creates a compliance “must-have” step that should be embedded into export workflows, including order processing, inventory release, documentation preparation, and shipment scheduling.
From an enforcement perspective, Regulation 6 provides meaningful criminal penalties. Even where the exporter has some regulatory involvement, exporting without a licence or outside licence terms can lead to prosecution. The maximum fine and imprisonment term are not the only practical risks: criminal proceedings can also trigger reputational harm, regulatory scrutiny, and potential downstream consequences for corporate licensing and business continuity.
For legal practitioners, the most important practical issues typically include: (i) confirming whether the substance or medicinal product is within the Schedule; (ii) ensuring that the exporter holds a valid export licence that corresponds to the exact consignment; (iii) verifying that the export is strictly within the licence’s terms and conditions; and (iv) maintaining documentary evidence to demonstrate compliance. Because Regulation 3 ties legality to consignment-specific licensing and licence conditions, counsel should advise clients to treat licence terms as operational constraints rather than administrative formalities.
Related Legislation
- Medicines Act (Cap. 176), including sections 22 and 74 (authorising provisions for these Regulations)
- Medicines (Export Licence for Psychotropic Substances) Regulations — the instrument analysed (Rg 9)
- Medicines Act (general framework for licensing, regulation of medicinal products, and enforcement—relevant for interpretation and compliance context)
Source Documents
This article provides an overview of the Medicines (Export Licence for Psychotropic Substances) Regulations for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.